Identification of translational dermatology research priorities in the U.K.: results of an electronic Delphi exercise.
Healy, E;
Brown, SJ;
Langan, SM;
Nicholls, SG;
Shams, K;
Reynolds, NJ;
(2015)
Identification of translational dermatology research priorities in the U.K.: results of an electronic Delphi exercise.
The British journal of dermatology, 173 (5).
pp. 1191-1198.
ISSN 0007-0963
DOI: https://doi.org/10.1111/bjd.14022
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
BACKGROUND: Translational research is the direct application of basic and applied research to patient care. It is estimated that there are at least 2000 different skin diseases; thus, there are considerable challenges in seeking to undertake research on each of these disorders. OBJECTIVES: This electronic Delphi (e-Delphi) exercise was conducted in order to generate a list of translational dermatology research questions that are regarded as a priority for further investigations. METHODS: During the first phase of the e-Delphi exercise, 228 research questions were generated by an expert panel that included clinical academic dermatologists, clinical dermatologists, nonclinical scientists, dermatology trainees and representatives from patient support groups. RESULTS: Following completion of the second and third phases, 40 questions on inflammatory skin disease, 20 questions on structural skin disorders/genodermatoses, 37 questions on skin cancer and eight miscellaneous questions were designated as priority translational dermatology research questions (PRQs). In addition to PRQs on a variety of disease areas (including multiple PRQs on psoriasis, eczema, squamous cell carcinoma and melanoma), there were a number of cross-cutting themes that identified a need to investigate mechanisms/pathogenesis of disease and the necessity to improve treatments for patients with skin disease. CONCLUSIONS: It is predicted that this list of PRQs will help to provide a strategic direction for translational dermatology research in the U.K. and that addressing this list of questions will ultimately provide clinical benefit for substantial numbers of patients with skin disorders.